BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3690188)

  • 41. Suppression of spermatogenesis in ipsilateral and contralateral testicular tissues in patients with seminoma by human chorionic gonadotropin beta subunit.
    Hayashi T; Arai G; Hyochi N; Suzuki M; Masuda H; Kawakami S; Okuno T; Ishizaka K; Kageyama Y; Kihara K
    Urology; 2001 Aug; 58(2):251-7. PubMed ID: 11489712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [HCG-positive cells in seminoma of the testis].
    Gotoh S; Fukui I; Yokokawa M; Aoki N; Kamiyama R
    Hinyokika Kiyo; 1984 Feb; 30(2):169-73. PubMed ID: 6204519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
    Javadpour N; McIntire KR; Waldmann TA; Bergman SM
    J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical evaluation on differential quantitation of human chorionic gonadotropin in testicular cancer].
    Nakamura K; Deguchi N; Nakanoma T; Hagiwara M; Tazaki H; Hata J
    Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):408-13. PubMed ID: 1694252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pure dysgerminoma of the ovary with elevated serum human chorionic gonadotropin: diagnostic and therapeutic considerations.
    Kapp DS; Kohorn EI; Merino MJ; LiVolsi VA
    Gynecol Oncol; 1985 Feb; 20(2):234-44. PubMed ID: 2579008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L; Bussar-Maatz R; Mann K
    Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of serum beta-chain human chorionic gonadotropin in the management of testis tumor.
    Walter MC
    Natl Cancer Inst Monogr; 1978 Dec; (49):219. PubMed ID: 748772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG).
    Munro AJ; Nielsen OS; Duncan W; Sturgeon J; Gospodarowicz MK; Malkin A; Thomas GM; Jewett MA
    Br J Cancer; 1991 Sep; 64(3):537-42. PubMed ID: 1716953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer.
    Bulger KN; Hesketh PJ; Babayan RK
    J Urol; 1989 Dec; 142(6):1574-5. PubMed ID: 2479778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
    Fowler JE; Taylor G; Blom J; Stutzman RE
    J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High level of beta hCG in spermatic vein of patients with seminoma.
    Fiet J; Jardin A; Guechot J; Villette JM
    Lancet; 1983 Nov; 2(8360):1195. PubMed ID: 6139549
    [No Abstract]   [Full Text] [Related]  

  • 53. The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.
    Narayana AS; Loening S; Culp DA
    Br J Urol; 1978 Dec; 50(7):605-8. PubMed ID: 88986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical outcome of adult testicular tumor. II. Study on patients with positive human chorionic gonadotropin].
    Sakuramoto T; Kihara K; Kawai T
    Hinyokika Kiyo; 1984 May; 30(5):639-49. PubMed ID: 6089533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. beta-HCG-positive seminoma of testis weighing 1 kg in a 59-year-old man.
    Steffens J; Hofstädter F
    Eur Urol; 1989; 16(2):151-2. PubMed ID: 2469586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testicular tumour markers in tissue correlated to serum levels and clinical stage.
    Alm P; Hultberg B; Olsson AM
    Scand J Urol Nephrol; 1984; 18(4):283-8. PubMed ID: 6209794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-orchiectomy radiotherapy for stages I and II testicular seminoma.
    Dosmann MA; Zagars GK
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):381-90. PubMed ID: 7685748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of stage I, II testicular tumor based on tumor markers].
    Kamidono S; Arakawa S; Hamami G; Umezu K; Fujii A; Ishigami J
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1383-93. PubMed ID: 6202917
    [No Abstract]   [Full Text] [Related]  

  • 59. [Assay of chorionic gonadotrophin, follicle-stimulating hormone and alpha-fetoprotein in the efferent blood in germinal tumors of the testis].
    Henry R; Wiriot G; Longeon A; Timbal Y; Degrelle H
    Presse Med; 1986 Jun; 15(26):1223-6. PubMed ID: 2428029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histologically pure stage I seminoma with an elevated beta-hCG of 4497 IU/l.
    Bjurlin MA; August CZ; Weldon-Linne M; Totonchi E
    Urology; 2007 Nov; 70(5):1007.e13-5. PubMed ID: 18068467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.